Molecular Insight Pharmaceuticals, Inc. (MIPI)
$4.00
-0.05 (-1.23%)
| CAPS Rating |
|
|---|---|
| Open | $4.06 |
| Previous Close | $4.05 |
| Daily Range | $3.90 - $4.33 |
| 52-Week Range | $1.15 - $7.90 |
| Market Cap | $101.07M |
| P/E Ratio | 0.00 |
| Dividend (Yield) | N/A (N/A) |
| Volume | 7,754 |
| Average Daily Volume | 43,000 |
MIPI
VS S&P 500 (SPY)
How do you think MIPI will perform vs the S&P 500?
Caps
Motley Fool CAPS is a community working together to find better stocks and to become better investors.
MIPI Advanced Details
- CAPS Community Analysis: Commentary, Scorecard
- Advanced Financial Analysis: Historical Prices, Chart, Stats, Ratios, Earnings/Growth Rates, Statements, SEC Filings
MIPI News and Commentary
- Shorting MIPI sure is turning into a nightmare.. – Blog at The Motley Fool
- FDA indicated a quick approval for MIPI 's Zemiva – Blog at The Motley Fool
- Moneyflow is shifting back into Safer Drug Sector – Blog at The Motley Fool
- MIPI potential greater than SVNT – Blog at The Motley Fool
Related News and Articles
- 4 Platform Drugmakers to Invest In – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- A Big Upgrade for Allos Therapeutics – The Motley Fool
- Now's a Great Time to Invest -- So Don't Blow It Like This – The Motley Fool
- This Stock Is a Train Wreck – The Motley Fool
- Drug Lowers Cholesterol; Stock Follows – The Motley Fool
- The Hottest Sector for 2010 – The Motley Fool
- Abbott: Brave or Stupid? – The Motley Fool
- 5-Star Stocks Poised to Pop: American Oriental Bioengineering – The Motley Fool
- Do You Have the Guts to Buy? – The Motley Fool
- This Top Stock Is a Winner – The Motley Fool
- Amylin Scores a Hat Trick – The Motley Fool
- 10 Stocks Shaking the Market – The Motley Fool
- This Just In: Upgrades and Downgrades – The Motley Fool
RSS Headlines
Fool UK
